Novacyt S.A. Stock
Your prediction
Novacyt S.A. Stock
A loss of -1.120% shows a downward development for Novacyt S.A..
Our community identified positive and negative aspects for Novacyt S.A. stock for the coming years. 1 users see the criterium "Valuation (undervalued/overvalued)" as a plus for the Novacyt S.A. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Novacyt S.A. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novacyt S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novacyt S.A. | -1.120% | - | - | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | 1.220% | -1.068% | 5.256% | - | 1.926% | - | - |
| Genoway S.A. Inh. | -2.940% | -4.149% | -4.149% | -37.736% | -6.855% | -45.131% | -33.811% |
| Sensorion SA | -0.370% | -14.557% | -14.013% | -58.462% | -8.163% | -21.626% | -84.958% |
